Selected Publications
-
López, A., Zobolas, J., Dumontier, T., Aittokallio T. Multi-modal learning with incomplete data. Nature Communications (2026)
-
Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM & Aittokallio T. A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia. NPJ Precision Oncology (2026)
-
Zobolas J, George AM, López A, Fischer S, Becker M, Aittokallio T. Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data. BioData Mining (2026)
-
Romero-Becerra R, Zhao Z, Nebdal D, Müller E, Bergholtz H, Norum JH & Aittokallio T.Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool. Nature Communications (2025)
-
Zhao Z, Zobolas J, Zucknick M, Aittokallio T. Tutorial on survival modeling with applications to omics data. Bioinformatics (2024)
-
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K & Aittokallio T. Robust scoring of selective drug responses for patient-tailored therapy selection. Nature Protocols (2024)
-
Zhao Z, Wang S, Zucknick M & Aittokallio T. Tissue-specific identification of multi-omics features for pan-cancer drug response prediction. iScience (2022)
-
Ianevski A, Giri AK & Aittokallio T. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nature Communications (2022)
-
Ianevski A, Lahtela J, Javarappa KK, Sergeev P, Ghimire BR, Gautam P, Vähä-Koskela M, Turunen L, Linnavirta N, Kuusanmäki H, Kontro M, Porkka K, Heckman CA, Mattila P, Wennerberg K, Giri AK & Aittokallio T. Patient-tailored design for selective co-inhibition of leukemic cell subpopulations. Science Advances (2021)